MYOS RENS Technology Market Cap 2008-2019 | MYOS

MYOS RENS Technology market cap history and chart from 2008 to 2019. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of diluted shares outstanding. MYOS RENS Technology market cap as of August 16, 2019 is $0.01B.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.014B $0.000B
MYOS RENS Technology Inc. is a BioNutrition and BioTherapeutics company which focused on the discovery, development and commercialization of products which improve muscle health and function essential to the management of sarcopenia, cachexia and degenerative muscle diseases. MYOS RENS Technology Inc., formerly known as MYOS Corporation, is based in Cedar Knolls, New Jersey.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.263B 13.58
Gilead Sciences (GILD) United States $79.939B 9.82
Celgene (CELG) United States $65.835B 10.19
Vertex Pharmaceuticals (VRTX) United States $46.146B 49.87
Illumina (ILMN) United States $41.905B 49.24
Biogen (BIIB) United States $41.818B 7.43
CSL (CSLLY) Australia $35.079B 0.00
Regeneron Pharmaceuticals (REGN) United States $32.239B 14.63
Alexion Pharmaceuticals (ALXN) United States $24.138B 12.73
Incyte (INCY) United States $17.433B 51.30
Exact Sciences (EXAS) United States $15.300B 0.00
SINO PHARMACEUT (SBMFF) China $15.039B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.869B 0.00
Genmab (GNMSF) Denmark $12.608B 64.09
Seattle Genetics (SGEN) United States $12.449B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.708B 52.04
Sarepta Therapeutics (SRPT) United States $9.188B 0.00
Guardant Health (GH) United States $9.176B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.791B 0.00
Galapagos (GLPG) Belgium $8.689B 0.00
QIAGEN (QGEN) Netherlands $7.803B 25.63
Bio-Techne Corp (TECH) United States $7.281B 50.33
BeiGene (BGNE) Cayman Islands $6.634B 0.00
Bluebird Bio (BLUE) United States $6.396B 0.00
Exelixis (EXEL) United States $6.028B 15.67
Amarin (AMRN) Ireland $5.294B 0.00
Horizon Pharma Public (HZNP) Ireland $4.963B 12.62
Ascendis Pharma (ASND) Denmark $4.822B 0.00
Repligen (RGEN) United States $4.576B 88.81
ARGENX SE-ADR (ARGX) Netherlands $4.308B 0.00
ACADIA Pharmaceuticals (ACAD) United States $4.207B 0.00
Moderna (MRNA) United States $4.207B 0.00
Blueprint Medicines (BPMC) United States $4.107B 0.00
Spark Therapeutics (ONCE) United States $3.803B 0.00
MorphoSys AG (MOR) Germany $3.726B 0.00
China Biologic Products (CBPO) China $3.721B 23.23
Mirati Therapeutics (MRTX) United States $3.591B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.444B 0.00
Alkermes (ALKS) Ireland $3.326B 0.00
Immunomedics (IMMU) United States $2.860B 0.00
Genomic Health (GHDX) United States $2.785B 52.24
Arena Pharmaceuticals (ARNA) United States $2.673B 5.74
Amicus Therapeutics (FOLD) United States $2.595B 0.00
NeoGenomics (NEO) United States $2.552B 136.50
CRISPR Therapeutics AG (CRSP) Switzerland $2.529B 0.00
Medicines (MDCO) United States $2.516B 0.00
MyoKardia (MYOK) United States $2.484B 0.00
Acceleron Pharma (XLRN) United States $2.390B 0.00
Halozyme Therapeutics (HALO) United States $2.315B 0.00
Emergent Biosolutions (EBS) United States $2.217B 33.30
Reata Pharmaceuticals (RETA) United States $2.194B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.140B 0.00
UniQure (QURE) Netherlands $2.116B 0.00
Cambrex (CBM) United States $2.024B 25.59
Akcea Therapeutics (AKCA) United States $1.998B 0.00
Zai Lab (ZLAB) China $1.973B 0.00
Myriad Genetics (MYGN) United States $1.884B 19.77
Ligand Pharmaceuticals (LGND) United States $1.779B 22.50
Denali Therapeutics (DNLI) United States $1.759B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.643B 0.00
AnaptysBio (ANAB) United States $1.392B 0.00
Insmed (INSM) United States $1.392B 0.00
REGENXBIO (RGNX) United States $1.351B 0.00
Sangamo Therapeutics (SGMO) United States $1.337B 0.00
RA PHARMCTL INC (RARX) United States $1.318B 0.00
Coherus BioSciences (CHRS) United States $1.297B 0.00
Editas Medicine (EDIT) United States $1.242B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.195B 0.00
Athenex (ATNX) United States $1.176B 0.00
Fate Therapeutics (FATE) United States $1.169B 0.00
Epizyme (EPZM) United States $1.163B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.141B 0.00
Innoviva (INVA) United States $1.135B 3.28
Alector (ALEC) United States $1.046B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.960B 0.00
Twist Bioscience (TWST) United States $0.946B 0.00
Zymeworks (ZYME) Canada $0.945B 0.00
Cara Therapeutics (CARA) United States $0.915B 0.00
Principia Biopharma (PRNB) United States $0.876B 456.75
BAVARIAN NORDIC (BVNRY) Denmark $0.853B 0.00
ANI Pharmaceuticals (ANIP) United States $0.850B 14.20
ZIOPHARM Oncology Inc (ZIOP) United States $0.837B 0.00
Intellia Therapeutics (NTLA) United States $0.826B 0.00
Arvinas (ARVN) United States $0.805B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.795B 0.00
Adverum Biotechnologies (ADVM) United States $0.790B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.788B 28.46
Codexis (CDXS) United States $0.760B 0.00
Anika Therapeutics (ANIK) United States $0.756B 26.76
Cytokineticsorporated (CYTK) United States $0.741B 0.00
Retrophin (RTRX) United States $0.741B 0.00
WAVE Life Sciences (WVE) Singapore $0.720B 0.00
Pharming Group (PHGUF) Netherlands $0.706B 0.00
Vericel (VCEL) United States $0.705B 0.00
Zealand Pharma (ZEAL) Denmark $0.680B 7.95
Zealand Pharma (ZLDPF) Denmark $0.672B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.665B 0.00
Stemline Therapeutics (STML) United States $0.651B 0.00
Heska (HSKA) United States $0.563B 72.91
MiMedx (MDXG) United States $0.561B 0.00
DBV Technologies S.A (DBVT) France $0.545B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.535B 0.00
Cellectis S.A (CLLS) France $0.508B 0.00
Revance Therapeutics (RVNC) United States $0.499B 0.00
Intra-Cellular Therapies (ITCI) United States $0.496B 0.00
Precision BioSciences (DTIL) United States $0.475B 0.00
Mesoblast (MESO) Australia $0.461B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
UROGEN PHARMA (URGN) United States $0.446B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.438B 0.00
CytomX Therapeutics (CTMX) United States $0.431B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.423B 0.00
Syros Pharmaceuticals (SYRS) United States $0.421B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.411B 0.00
Puma Biotechnology (PBYI) United States $0.391B 0.00
PHARMA MAR SA (PHMMF) Spain $0.387B 0.00
BioDelivery Sciences (BDSI) United States $0.383B 0.00
Agenus (AGEN) United States $0.373B 0.00
Merus (MRUS) Netherlands $0.367B 0.00
AC Immune SA (ACIU) Switzerland $0.366B 27.05
Avid Bioservices (CDMO) United States $0.355B 0.00
Gritstone Oncology (GRTS) United States $0.346B 0.00
Kadmon Holdings (KDMN) United States $0.328B 0.00
Prothena (PRTA) Ireland $0.325B 0.00
Biofrontera AG (BFRA) Germany $0.323B 0.00
Arcus Biosciences (RCUS) United States $0.321B 0.00
Starpharma Holdings (SPHRY) Australia $0.310B 0.00
Theratechnologies (THERF) Canada $0.309B 0.00
Bellus Health (BLUSF) Canada $0.306B 0.00
PDL BioPharma (PDLI) United States $0.299B 7.71
Albireo Pharma (ALBO) United States $0.298B 0.00
Clovis Oncology (CLVS) United States $0.292B 0.00
Cel-Sci (CVM) United States $0.284B 0.00
Scholar Rock Holding (SRRK) United States $0.281B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.277B 0.00
Kindred Biosciences (KIN) United States $0.275B 0.00
Sorrento Therapeutics (SRNE) United States $0.269B 0.00
Protagonist Therapeutics (PTGX) United States $0.260B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.249B 0.00
Cellular Biomedicine (CBMG) United States $0.246B 0.00
Dynavax Technologies (DVAX) United States $0.244B 0.00
Geron (GERN) United States $0.243B 0.00
Senesco Technologies (ELOX) United States $0.241B 0.00
ChromaDex (CDXC) United States $0.240B 0.00
ADMA Biologics Inc (ADMA) United States $0.233B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.228B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.228B 0.00
Inovio Pharmaceuticals (INO) United States $0.226B 0.00
Pfenex (PFNX) United States $0.216B 0.00
Kamada (KMDA) Israel $0.212B 8.10
Five Prime Therapeutics (FPRX) United States $0.206B 0.00
MannKind (MNKD) United States $0.201B 0.00
Seres Therapeutics (MCRB) United States $0.200B 0.00
Sutro Biopharma (STRO) United States $0.196B 0.00
Palatin Technologies (PTN) United States $0.190B 0.00
CorMedix Inc (CRMD) United States $0.189B 0.00
Compugen (CGEN) Israel $0.188B 0.00
Athersys (ATHX) United States $0.185B 0.00
PHASEBIO PHARMA (PHAS) United States $0.182B 0.00
Spero Therapeutics (SPRO) United States $0.177B 0.00
Affimed (AFMD) Germany $0.176B 0.00
Cue Biopharma (CUE) United States $0.171B 0.00
POXEL SA FRANCE (PXXLF) $0.167B 0.00
Dyadic (DYAI) United States $0.165B 0.00
Newron Pharmaceuticals SpA (NWPHF) $0.165B 0.00
Enzo Biochem (ENZ) United States $0.162B 0.00
Emmaus Life Sciences (EMMA) United States $0.160B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.159B 0.00
OSMOTICA PHARM (OSMT) United States $0.155B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.154B 0.00
Synlogic (SYBX) United States $0.151B 0.00
Nicox SA (NICXF) France $0.150B 0.00
Cerecor (CERC) United States $0.148B 0.00
XOMA (XOMA) United States $0.146B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.146B 0.00
Novavax (NVAX) United States $0.144B 0.00
Arsanis (XFOR) United States $0.144B 0.00
Strongbridge Biopharma (SBBP) United States $0.143B 5.87
Adocia (ADOCY) France $0.140B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.136B 0.00
Mersana Therapeutics (MRSN) United States $0.132B 0.00
NantKwest (NK) United States $0.126B 0.00
Windtree Therapeutics (WINT) United States $0.126B 0.00
Northwest Biotherapeutics (NWBO) United States $0.121B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.120B 0.00
Abeona Therapeutics (ABEO) United States $0.120B 0.00
Alcobra (ARCT) United States $0.119B 0.00
Celyad SA (CYAD) Belgium $0.115B 0.00
Acorda Therapeutics (ACOR) United States $0.115B 0.00
Liquidia Technologies (LQDA) United States $0.114B 0.00
SESEN BIO, INC (SESN) United States $0.112B 0.00
Aptinyx (APTX) United States $0.110B 0.00
Fortress Biotech (FBIO) United States $0.109B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.106B 0.00
Aduro Biotech (ADRO) United States $0.103B 0.00
TOCAGEN INC (TOCA) United States $0.103B 0.00
Verastem (VSTM) United States $0.099B 0.00
Checkpoint Therapeutics (CKPT) United States $0.094B 0.00
OvaScience (MLND) United States $0.093B 0.00
Catalyst Biosciences (CBIO) United States $0.088B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.087B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.087B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.087B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.084B 0.00
Arbutus Biopharma (ABUS) Canada $0.084B 0.00
Trevena (TRVN) United States $0.083B 0.00
Menlo Therapeutics (MNLO) United States $0.077B 0.00
Selecta Biosciences (SELB) United States $0.076B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.075B 0.00
Orgenesis (ORGS) United States $0.073B 0.00
ARAVIVE, INC (ARAV) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.071B 0.00
VTv Therapeutics (VTVT) United States $0.069B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.068B 0.00
AquaBounty Technologies (AQB) United States $0.067B 0.00
Idera Pharmaceuticals (IDRA) United States $0.065B 0.00
Applied Genetic Technologies (AGTC) United States $0.063B 34.70
Antibe Therapeutics (ATBPF) Canada $0.063B 0.00
VBI Vaccines (VBIV) United States $0.062B 0.00
Curis (CRIS) United States $0.062B 0.00
Oncobiologics (OTLK) United States $0.060B 0.00
Pluristem Therapeutics (PSTI) Israel $0.059B 0.00
NewLink Genetics (NLNK) United States $0.056B 0.00
Vaccinex (VCNX) United States $0.056B 0.00
Unum Therapeutics (UMRX) United States $0.056B 0.00
AIT Therapeutics (XAIR) United States $0.054B 0.00
Prima BioMed (IMMP) Australia $0.052B 0.00
Ophthotech (ISEE) United States $0.046B 0.00
Clearside Biomedical (CLSD) United States $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.043B 0.00
Evogene (EVGN) Israel $0.042B 0.00
Alimera Sciences (ALIM) United States $0.039B 0.00
Protalix BioTherapeutics (PLX) Israel $0.036B 0.00
VIVUS (VVUS) United States $0.036B 0.00
Apricus Biosciences (SEEL) United States $0.036B 0.00
AEterna Zentaris (AEZS) United States $0.035B 0.00
Organovo Holdings (ONVO) United States $0.035B 0.00
Proteostasis Therapeutics (PTI) United States $0.035B 0.00
Celsion (CLSN) United States $0.035B 0.00
Aptevo Therapeutics (APVO) United States $0.034B 0.00
Celldex Therapeutics (CLDX) United States $0.032B 0.00
BIOCARDIA INC (BCDA) United States $0.031B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.030B 0.00
DiaMedica Therapeutics (DMAC) United States $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Signal Genetics (MGEN) United States $0.026B 0.00
Entera Bio (ENTX) Israel $0.024B 0.16
Aytu Bioscience (AYTU) United States $0.023B 0.00
VistaGen Therapeutics (VTGN) United States $0.020B 0.00
Bionano Genomics (BNGO) United States $0.020B 0.00
Soligenix (SNGX) United States $0.020B 0.00
Vical (VICL) United States $0.018B 0.00
Fibrocell Science Inc (FCSC) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.016B 0.00
Cleveland BioLabs (CBLI) United States $0.016B 0.00
TRACON Pharmaceuticals (TCON) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
CollPlant Holdings (CLGN) Israel $0.014B 0.00
Novelion Therapeutics (NVLN) Canada $0.013B 0.00
IBio (IBIO) United States $0.013B 0.00
IMMURON (IMRN) Australia $0.011B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
Prana Biotechnology (ATHE) Australia $0.010B 0.00
AmpliPhi Biosciences (ARMP) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.008B 0.00
TrovaGene (TROV) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Advaxis (ADXS) United States $0.007B 0.00
Hemispherx BioPharma (HEB) United States $0.004B 0.00
Stellar Biotechnologies (EDSA) United States $0.004B 0.00
BioPharmX (BPMX) United States $0.003B 0.00
Neuralstem (CUR) United States $0.002B 0.00